Authors:
Keller, MB
McCullough, JP
Klein, DN
Arnow, B
Dunner, DL
Gelenberg, AJ
Markowitz, JC
Nemeroff, CB
Russell, JM
Thase, ME
Trivedi, MH
Zajecka, J
Blalock, JA
Borian, FE
Jody, DN
DeBattista, C
Koran, LM
Schatzberg, AF
Fawcett, J
Hirschfeld, RMA
Keitner, G
Miller, I
Kocsis, JH
Kornstein, SG
Manber, R
Ninan, PT
Rothbaum, B
Rush, AJ
Vivian, D
Rothbaum, B
Citation: Mb. Keller et al., A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression, N ENG J MED, 342(20), 2000, pp. 1462-1470
Citation: Jc. Markowitz, Cognitive psychotherapy of psychotic and personality disorders: Handbook of theory and practice, AM J PSYCHI, 157(3), 2000, pp. 479-479
Authors:
Klein, DN
Schatzberg, AF
McCullough, JP
Dowling, F
Goodman, D
Howland, RH
Markowitz, JC
Smith, C
Thase, ME
Rush, AJ
LaVange, L
Harrison, WM
Keller, MB
Citation: Dn. Klein et al., Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response, J AFFECT D, 55(2-3), 1999, pp. 149-157
Authors:
Friedman, RA
Markowitz, JC
Parides, M
Gniwesch, L
Kocsis, JH
Citation: Ra. Friedman et al., Six months of desipramine for dysthymia: can dysthymic patients achieve normal social functioning?, J AFFECT D, 54(3), 1999, pp. 283-286
Authors:
Klein, DN
Schatzberg, AF
McCullough, JP
Keller, MB
Dowling, F
Goodman, D
Howland, RH
Markowitz, JC
Smith, C
Miceli, R
Harrison, WM
Citation: Dn. Klein et al., Early- versus late-onset dysthymic disorder: comparison in out-patients with superimposed major depressive episodes, J AFFECT D, 52(1-3), 1999, pp. 187-196
Authors:
Miller, NL
Markowitz, JC
Kocsis, JH
Leon, AC
Brisco, ST
Garno, JL
Citation: Nl. Miller et al., Cost effectiveness of screening for clinical trials by research assistantsversus senior investigators, J PSYCH RES, 33(2), 1999, pp. 81-85
Authors:
Piazza, LA
Markowitz, JC
Kocsis, JH
Leon, AC
Portera, L
Miller, NL
Citation: La. Piazza et al., Sexual functioning with selective serotonin reuptake inhibitors - Dr. Piazza and colleagues reply, AM J PSYCHI, 156(5), 1999, pp. 808-808
Authors:
Rush, AJ
Koran, LM
Keller, MB
Markowitz, JC
Harrison, WM
Miceli, RJ
Fawcett, JA
Gelenberg, AJ
Hirschfeld, RMA
Klein, DN
Kocsis, JH
McCullough, JP
Schatzberg, AF
Thase, ME
Citation: Aj. Rush et al., The treatment of chronic depression, part 1: Study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies, J CLIN PSY, 59(11), 1998, pp. 589-597
Authors:
Keller, MB
Gelenberg, AJ
Hirschfeld, RMA
Rush, AJ
Thase, ME
Kocsis, JH
Markowitz, JC
Fawcett, JA
Koran, LM
Klein, DN
Russell, JM
Kornstein, SG
McCullough, JP
Davis, SM
Harrison, WM
Citation: Mb. Keller et al., The treatment of chronic depression, part 2: A double-blind, randomized trial of sertraline and imipramine, J CLIN PSY, 59(11), 1998, pp. 598-607
Authors:
Miller, IW
Keitner, GI
Schatzberg, AF
Klein, DN
Thase, ME
Rush, AJ
Markowitz, JC
Schlager, DS
Kornstein, SG
Davis, SM
Harrison, WM
Keller, MB
Citation: Iw. Miller et al., The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine, J CLIN PSY, 59(11), 1998, pp. 608-619